COVID-19 replicating RNA vaccine has robust response in nonhuman primates
2 institutional releases
Published in Science Translational Medicine · View the paper (DOI)
A replicating RNA vaccine has shown robust immune response in both young and old animal models, producing antibodies comparable to those in people recovering from COVID-19. The vaccine's design avoids immune responses that could exacerbate the virus, instead inducing protective antiviral measures and T cells.
Coverage from 2 institutions
- COVID-19 replicating RNA vaccine has robust response in nonhuman primates University of Washington School of Medicine/UW Medicine · Jul 20, 2020 · first to report
- A nanoparticle vaccine for SARS-CoV-2 produces signs of immunity in mice and macaques American Association for the Advancement of Science (AAAS) · Jul 20, 2020